Homology Medicines, Inc.

BEDFORD, MA How do I update this listing?

Homology Medicines is based out of Bedford. Homology Medicines, Inc. operates as a genetic medicines company. The Company offers a platform to utilize human hematopoietic stem cell derived adeno-associated virus vectors to treat a range of disease-causing mutations through gene correction, insertion, and knockout. Homology Medicines serves patients in the United States. The firm last filed a Form D notice of exempt offering of securities on 2017-08-10. The notice included securities offered of Equity

Create Alert

Contact Info

homology medicines, inc.
ONE PATRIOTS PARK
BEDFORD MA    01730

Business Phone: 781-301-7277
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-08-10 D PHARMACEUTICALS Equity 83,500,008 83,500,008 0
2017-02-16 D/A PHARMACEUTICALS Equity 43,568,874 43,568,874 0
2016-01-06 D PHARMACEUTICALS Equity 23,068,876 23,068,876 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALBERT SEYMOUR subscription required
    EXECUTIVE OFFICER
ARTHUR TZIANABOS subscription required
    EXECUTIVE OFFICER DIRECTOR
BRAD SMITH subscription required
    EXECUTIVE OFFICER
CAMERON WHEELER subscription required
    DIRECTOR
KUSH PARMAR subscription required
    EXECUTIVE OFFICER DIRECTOR
MAHENDRA SHAH subscription required
    DIRECTOR
PAUL STONE subscription required
    EXECUTIVE OFFICER DIRECTOR
RICHARD GREGORY subscription required
    DIRECTOR
SIYAMAK RASTY subscription required
    EXECUTIVE OFFICER
STEVEN GILLIS subscription required
    DIRECTOR

Elevate your investments